Loading…
for educational and safety purposes
Methoxetamine and Deschloroketamine both come up in the same conversations; they overlap on Glutamate and Pain. Methoxetamine: Methoxetamine (MXE) is an arylcyclohexylamine dissociative developed as a ketamine analog and widely sold as a research chemical before international bans. Deschloroketamine: Deschloroketamine (DCK) is an arylcyclohexylamine dissociative and a ketamine analogue in which the aromatic chlorine of ketamine is removed.
Methoxetamine (MXE) is an arylcyclohexylamine dissociative developed as a ketamine analog and widely sold as a research chemical before international bans. It acts as a potent uncompetitive antagonist at the NMDA glutamate receptor, binding the phencyclidine site within the channel pore to produce dissociative, anesthetic, and psychotomimetic effects; unlike ketamine it also engages serotonergic systems, raising cortical and accumbal serotonin and relying partly on 5-HT2 receptors for some of its sensorimotor effects. Its longer duration and greater intensity relative to ketamine, marketed misleadingly as "bladder friendly," were accompanied by reports of abuse, urinary and cerebellar toxicity, and fatal intoxications. Paradoxically, preclinical work has also identified rapid antidepressant-like effects mediated through glutamatergic and AMPA-receptor signaling, mirroring ketamine.
Deschloroketamine (DCK) is an arylcyclohexylamine dissociative and a ketamine analogue in which the aromatic chlorine of ketamine is removed. Like ketamine and related arylcyclohexylamines, it is presumed to act principally as an antagonist at the N-methyl-D-aspartate (NMDA) glutamate receptor, producing dissociative and anaesthetic-like effects, and users report a comparatively longer duration than ketamine. It emerged on the new psychoactive substance market alongside the fluorinated analogue 2-fluorodeschloroketamine (2F-DCK), of which DCK is also a metabolite, and forensic studies have mapped its extensive hepatic metabolism and urinary and hair biomarkers. Addictovigilance and toxicology reports associate DCK and its congeners with dissociation, impaired consciousness, redosing, and serious outcomes including fatalities, and chronic heavy use carries the urinary and bladder toxicity concerns characteristic of the ketamine class.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
antagonist
Antagonist
reuptake inhibitor
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.